JPRN-UMIN000018624
Completed
Phase 2
A phase II randomized controlled trial comparing perioperative mFOLFOXIRI with perioperative chemoradiotherapy for locally advanced rectal cancer. - A phase II randomized controlled trial comparing perioperative mFOLFOXIRI with perioperative chemoradiotherapy for locally advanced rectal cancer.
Osaka Medical College Hospital0 sites34 target enrollmentAugust 10, 2015
ConditionsRectal cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Rectal cancer
- Sponsor
- Osaka Medical College Hospital
- Enrollment
- 34
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Currently treated with systemic steroids or immunosuppressive agent 2\. Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma 3\. Infectious disease to be treated 4\. Positive for HBs antigen 5\. Uncontrollable hypertension, Uncontrollable diabetes mellitus, Uncontrollable arrhythmia, and severe clinical problem 6\. Grade 1 or more peripheral neuropathy 7\. Women during pregnancy, possible pregnancy or breast\-feeding 8\. Severe mental disease 9\. Attending physician determines that the case was inappropriate as the subject of this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
A clinical trial comparing pulmonary complications in two routes of gastric conduit placement after esophagectomyHealth Condition 1: C158- Malignant neoplasm of overlappingsites of esophagusCTRI/2024/02/062245AIIMS NEW DELHI
Not yet recruiting
Phase 2
A phase II Randomized controlled trial A comparison of short-course radiation and chemotherapy with or without intraperitoneal paclitaxel for locally advanced, non-metastatic signet-ring cell rectal cancersCTRI/2024/04/065785Tata Memorial Centre
Recruiting
Phase 2
A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopicJPRN-jRCT1040220153Takeuchi Hiroya90
Active, not recruiting
Phase 1
A randomized comparative phase II trial evaluating the capacity of the dualcombination doravirine/raltegravir to maintain virological success in HIV-1infected patients with an HIV-RNA plasma viremia below 50 copies/mL under acurrent antiretroviral regimen.HIV-1 INFECTIONTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2019-004195-19-ITCentre de Recherche et d’Etudes sur la Pathologie Tropical et le Sida (CREPATS)150
Active, not recruiting
Phase 1
A randomized comparative phase II trial evaluating the capacity of the dual combination doravirine/raltegravir to maintain virological success in HIV-1 infected patients with an HIV-RNA plasma viremia below 50 copies/mL under a current antiretroviral regimeEUCTR2019-004195-19-FRCentre de Recherche et d’Etudes sur la Pathologie Tropicale et le Sida (CREPATS)150